Eli Lilly and Company (LLY) announced a $1 billion expansion of Limerick, Ireland, manufacturing site to increase production of biologic active ingredients, including those for recently approved treatment for early symptomatic Alzheimer's disease. This brings Lilly's total Limerick investment to $2 billion, doubling the investment the company announced in March 2023.

礼来公司（Eli Lilly and Company，LLY）宣布斥资10亿美元扩建爱尔兰利默里克（Limerick）的生产基地，以增加生物活性成分的产量，包括最近批准用于治疗早期症状性阿尔茨海默氏病的生物活性成分。这使礼来公司在利默里克的总投资达到20亿美元，比该公司在2023年3月宣布的投资翻了一番。

Lilly will create another 150 jobs for highly skilled workers in Limerick, for a total of 450 employees.The company also unveiled $800 million facility expansion in Kinsale, Ireland, which began making medicines last year to meet demand for latest diabetes and obesity treatments.For More Such Health News, visit rttnews.com.

礼来公司将为利默里克的高技能工人创造另外150个工作岗位，总共450名员工。该公司还宣布在爱尔兰金赛尔投资8亿美元扩建工厂，该工厂去年开始生产药品，以满足最新糖尿病和肥胖症治疗的需求。欲了解更多此类健康新闻，请访问rttnews.com。

For comments and feedback contact: editorial@rttnews.comBusiness News.

如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股